Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!

>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur

Summary:

FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled

Summary:

Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Information on Meningitis Multi-State Outbreak

Friday, October 05, 2012

UPDATED:  As you may be aware, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are currently investigating a recent outbreak of fungal meningitis among patients who received an epidural steroid injection after May 21, 2012.  Seven deaths have been reported as of October 7, 2012.  Our thoughts and prayers are with the patients and their families affected by this horrific tragedy.

It is important to remind patients:

  • Steroid injections are safe.
  • These cases are associated with a potentially contaminated batch of medication.
  • Investigation into the exact source of the contamination is ongoing; however, interim data show that all infected patients received injection with preservative-free methylprednisolone acetate (80mg/ml) prepared by New England Compounding Center (NECC), located in Framingham, Mass.
  • As of Oct. 3, 2012, NECC has voluntarily shut down.
  • As of Oct. 7, 2012, NECC has voluntarily recalled all of its products. 
  • Fungal meningitis is not transmitted from person to person.

If patients have questions or concerns, they should contact their immediate health care provider.

FDA and CDC recommend that healthcare professionals cease use of any product produced by the NECC until further information is available.  NECC has recall of its products.

For more information concerning the recalled lots, or to read the full statements, including recommendations, from FDA and CDC, access the resources below:

 

« Back to Washington Alerts